Veterinary Medicines

HIPRAVIAR-TRT4

Authorised
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
Download as PDF

Product identification

Medicine name:
HIPRAVIAR-TRT4
Active substance:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
  • Avian infectious bronchitis virus, strain H52, Inactivated
  • Newcastle disease virus, strain La Sota, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Turkey rhinotracheitis virus, strain 1062, Inactivated
    6.00
    log10 (50% tissue culture infectious dose)/dose
    /
    1.00
    Dose
  • Infectious bursal disease virus, strain Winterfield 2512 (intermediate plus), Live
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, strain H52, Inactivated
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain La Sota, Inactivated
    819.00
    haemagglutinating units
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-2434/09.12.2014
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."